Advanced search
Publication Cover
Acta Oncologica Volume 48, 2009 - Issue 6
Journal homepage
805
Views
21
CrossRef citations to date
0
Altmetric
Original Article

Reproducibility of human epidermal growth factor receptor 2 analysis in primary breast cancer – A national survey performed at pathology departments in Sweden

Lisa Rydén Department of Surgery, University Hospital, Lund, Sweden
,
Monica Haglund Department of Pathology, Malmö University Hospital, Malmö, Sweden
,
Pär-Ola Bendahl Department of Oncology, University Hospital, Lund, Sweden
,
Thomas Hatschek Department of Oncology, Karolinska University Hospital in Solna, Stockholm, Sweden
,
Aleksandra Kolaric Department of Pathology, University Hospital, Örebro, Sweden
,
Anikó Kovács Department of Pathology, Sahlgrenska University Hospital, Gothenburg, Sweden
,
Ann Olsson Department of Pathology, Karolinska University Hospital in Solna, Stockholm, Sweden
,
Hans Olsson Department of Pathology, University Hospital, Linköping, Sweden
,
Carina Strand Department of Oncology, University Hospital, Lund, Sweden
,
Mårten Fernö Department of Oncology, University Hospital, Lund, SwedenCorrespondence[email protected]
&
Swedish Her2 Analysis Group Department of Surgery, University Hospital, Lund, Sweden
 show all
Pages 860-866 | Received 22 Dec 2008, Published online: 13 Aug 2009

Citations (21)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Maria Ekholm, Dorthe Grabau, Pär-Ola Bendahl, Jonas Bergh, Göran Elmberger, Hans Olsson, Leila Russo, Giuseppe Viale & Mårten Fernö. (2015) Highly reproducible results of breast cancer biomarkers when analysed in accordance with national guidelines – a Swedish survey with central re-assessment. Acta Oncologica 54:7, pages 1040-1048.
Read now
Heikki Joensuu, Pirkko-Liisa Kellokumpu-Lehtinen, Riikka Huovinen, Arja Jukkola-Vuorinen, Minna Tanner, Riitta Kokko, Johan Ahlgren, Päivi Auvinen, Outi Saarni, Leena Helle, Kenneth Villman, Paul Nyandoto, Greger Nilsson, Mika Leinonen, Vesa Kataja, Petri Bono & Henrik Lindman. (2014) Outcome of patients with HER2-positive breast cancer treated with or without adjuvant trastuzumab in the Finland Capecitabine Trial (FinXX). Acta Oncologica 53:2, pages 186-194.
Read now
Hans Olsson, Ing-Marie Fyhr, Per Hultman & Staffan Jahnson. (2012) HER2 status in primary stage T1 urothelial cell carcinoma of the urinary bladder. Scandinavian Journal of Urology and Nephrology 46:2, pages 102-107.
Read now
Ulla Wilking, Bengt Jönsson, Nils Wilking & Jonas Bergh. (2010) Trastuzumab use in breast cancer patients in the six Health Care Regions in Sweden. Acta Oncologica 49:6, pages 844-850.
Read now

Articles from other publishers (17)

Sander Ellegård, Kristina Engvall, Mustafa Asowed, Anna-Lotta Hallbeck, Nils Elander & Olle Stål. (2022) Long-term follow-up of early stage HER2-positive breast cancer patients treated with trastuzumab: A population-based real world multicenter cohort study. Frontiers in Oncology 12.
Crossref
Balazs Acs, Irma Fredriksson, Caroline Rönnlund, Catharina Hagerling, Anna Ehinger, Anikó Kovács, Rasmus Røge, Jonas Bergh & Johan Hartman. (2021) Variability in Breast Cancer Biomarker Assessment and the Effect on Oncological Treatment Decisions: A Nationwide 5-Year Population-Based Study. Cancers 13:5, pages 1166.
Crossref
Karama Asleh, Heather Ann Brauer, Amy Sullivan, Susanna Lauttia, Henrik Lindman, Torsten O. Nielsen, Heikki Joensuu, E. Aubrey Thompson & Saranya Chumsri. (2020) Predictive Biomarkers for Adjuvant Capecitabine Benefit in Early-Stage Triple-Negative Breast Cancer in the FinXX Clinical Trial. Clinical Cancer Research 26:11, pages 2603-2614.
Crossref
Shabaz Majid, Lisa Rydén & Jonas Manjer. (2019) Determinants for non-sentinel node metastases in primary invasive breast cancer: a population-based cohort study of 602 consecutive patients with sentinel node metastases. BMC Cancer 19:1.
Crossref
Shabaz Majid, Lisa Rydén & Jonas Manjer. (2018) Predictive factors for sentinel node metastases in primary invasive breast cancer: a population-based cohort study of 2552 consecutive patients. World Journal of Surgical Oncology 16:1.
Crossref
Christian BruefferJohan Vallon-Christersson, Dorthe GrabauAnna EhingerJari HäkkinenCecilia HegardtJanne MalinaYilun ChenPär-Ola BendahlJonas ManjerMartin MalmbergChrister LarssonNiklas Loman, Lisa RydénÅke BorgLao H. Saal. (2018) Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative. JCO Precision Oncology:2, pages 1-18.
Crossref
Onder Onguru & Paul J. Zhang. (2016) The relation between percentage of immunostained cells and amplification status in breast cancers with equivocal result for Her2 immunohistochemistry. Pathology - Research and Practice 212:5, pages 381-384.
Crossref
Henrik O. Helin, Vilppu J. Tuominen, Onni Ylinen, Heikki J. Helin & Jorma Isola. (2015) Free digital image analysis software helps to resolve equivocal scores in HER2 immunohistochemistry. Virchows Archiv 468:2, pages 191-198.
Crossref
Fatemeh Bahreini, Ali Reza Soltanian & Parvin Mehdipour. (2014) A meta-analysis on concordance between immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) to detect HER2 gene overexpression in breast cancer. Breast Cancer 22:6, pages 615-625.
Crossref
Christian Garbar, Aude-Marie Savoye, Corinne Mascaux, Eva Brabencova & Hervé Curé. (2014) The Human Epidermal Growth Factor Receptor 2 Screening Tests for Breast Cancer Suggested by the New Updated Recommendation of the American Society of Clinical Oncology/College of American Pathologists Will Involve a Rise of the In-Situ Hybridization Tests for the European Laboratories of Pathology. ISRN Oncology 2014, pages 1-6.
Crossref
Anna-Karin Falck, Mårten Fernö, Pär-Ola Bendahl & Lisa Rydén. (2013) St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases - aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trial. BMC Cancer 13:1.
Crossref
N. Pathmanathan & A. Michael Bilous. (2012) HER2 testing in breast cancer: an overview of current techniques and recent developments. Pathology 44:7, pages 587-595.
Crossref
W. Eiermann, J. Bergh, F. Cardoso, P. Conte, J. Crown, N.J. Curtin, J. Gligorov, B. Gusterson, H. Joensuu, B.K. Linderholm, M. Martin, F. Penault-Llorca, B.C. Pestalozzi, E. Razis, C. Sotiriou, S. Tjulandin & G. Viale. (2012) Triple negative breast cancer: Proposals for a pragmatic definition and implications for patient management and trial design. The Breast 21:1, pages 20-26.
Crossref
Aleix Prat, Matthew J. Ellis & Charles M. Perou. (2011) Practical implications of gene-expression-based assays for breast oncologists. Nature Reviews Clinical Oncology 9:1, pages 48-57.
Crossref
Harald Choritz, Guntram Büsche & Hans Kreipe. (2011) Quality assessment of HER2 testing by monitoring of positivity rates. Virchows Archiv 459:3, pages 283-289.
Crossref
Ulla Wilking, Eva Karlsson, Lambert Skoog, Thomas Hatschek, Elisabet Lidbrink, Goran Elmberger, Hemming Johansson, Linda Lindström & Jonas Bergh. (2010) HER2 status in a population-derived breast cancer cohort: discordances during tumor progression. Breast Cancer Research and Treatment 125:2, pages 553-561.
Crossref
Anna‐Karin Falck, Mårten Fernö, Pär‐Ola Bendahl & Lisa Rydén. (2010) Does Analysis of Biomarkers in Tumor Cells in Lymph Node Metastases Give Additional Prognostic Information in Primary Breast Cancer?. World Journal of Surgery 34:7, pages 1434-1441.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.